Below are the most recent publications written about "Antimalarials" by people in Profiles.
-
Asua V, Niaré K, Garg S, Legac J, Tukwasibwe S, Katairo T, Bohissou FE, Crudale RM, Simkin A, Mulondo J, Nsobya SL, Ssewanyana I, Dorsey G, Bailey JA, Kamya MR, Yeka A, Rosenthal PJ, Borrmann S, Conrad MD. Multiple local PfDHFR I164L haplotype expansions drive Plasmodium falciparum antifolate resistance in Uganda. Nat Commun. 2026 Sep 04; 17(1).
-
Niaré K, Tafesse B, Treat M, Sadler JM, Okitwi M, Orena S, Asua V, Kreutzfeld O, Legac J, Marglous J, Nsobya SL, Yeka A, Richard D, Ferdig MT, Mukherjee A, Rosenthal PJ, Juliano JJ, Bailey JA, Conrad MD. Emergence and spread of Plasmodium falciparum PX1 polymorphisms associated with decreased susceptibility to antimalarials in Uganda. Nat Med. 2026 Sep; 32(9):3192-3202.
-
Geleta D, Brhane BG, Abera A, Belachew M, Sime H, Gebreegziaxher A, Getu M, Ali A, Tesfay N, Habtetsion M, Kokobe B, Kebede M, Worku Z, Tasew G, Tadesse G, Tollera G, Fola AA, Bailey JA, Juliano JJ, Parr JB, Abte M, Assefa A. Recurrent parasitemias with artemisinin partial resistance mutations during the 2024 Ethiopia malaria resurgence: a case series. Malar J. 2026 Jul 31; 25(1).
-
Connelly SV, Cunningham C, Petrow I, Rustamzade N, Zuromski J, Sipolski DM, Nixon CP, Kurtis JD, Juliano JJ, Bailey JA, Oduor CI. Single-cell transcriptional changes of artemisinin-sensitive K13C580 and artemisinin-resistant K13580YPlasmodium falciparum upon dihydroartemisinin exposure. Front Cell Infect Microbiol. 2026; 16:1816105.
-
Carey-Ewend K, Shepard H, Yang G, Odas M, Ernest Peter E, Credo Dominick M, Rutha I, Amagai K, Vasquez-Martinez B, Mulei LA, Chhetri S, Kharabora O, Adams JH, Lin FC, Bailey J, Edwards JK, Gower EW, Juliano JJ, Ngasala BE, Lin JT. Frequent Plasmodium ovale Recurrence in Coastal Tanzania. Clin Infect Dis. 2026 07 08; 82(6):1044-1051.
-
Popkin-Hall ZR, Carey-Ewend K, Aghakhanian F, Oriero EC, Seth MD, Kashamuka MM, Ngasala B, Ali IM, Mukomena ES, Mandara CI, Kharabora O, Sendor R, Simkin A, Amambua-Ngwa A, Tshefu A, Fola AA, Ishengoma DS, Bailey JA, Parr JB, Lin JT, Juliano JJ. Population genomics of Plasmodium malariae from 4 African countries. JCI Insight. 2026 06 22; 11(12).
-
Connelly SV, Muller JG, Ali M, Ngasala BE, Hassan W, Mohamed B, Thwai KL, Sadler JM, Marglous J, Fola AA, Zacharia A, Shija SJ, Mohammed S, C Msolo D, Said H, Peter EE, Odas M, Rutha IJ, Nwange M, Naire K, Ruybal-Pesántez S, Verity R, Crudale R, Goel V, Choloi BB, Björkman A, Bailey JA, Lin JT, Juliano JJ. Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023. J Infect Dis. 2026 Feb 18; 233(2):e491-e495.
-
Zeleke AJ, Fola AA, Tollefson GA, Niaré K, Leonetti A, Taropawala O, Marglous J, Crudale R, Brhane BG, Assefa A, Kiyuka P, Parr JB, Hailu A, Tegegne MA, Bailey JA. High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. PLoS Pathog. 2025 12; 21(12):e1013771.
-
Gashema P, Jordan A, Saramba E, Wernsman Young N, Iradukunda PG, Karema C, Mazarati JB, Juliano JJ, Bailey JA, Banek K. Understanding Malaria Treatment Adherence in Rwanda: Implications for Artemisinin Resistance. Am J Trop Med Hyg. 2025 Dec 03; 113(6):1279-1288.
-
Martin AC, Sadler JM, Simkin A, Musonda M, Katowa B, Matoba J, Schue J, Simulundu E, Bailey JA, Moss WJ, Juliano JJ, Fola AA. Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia. J Infect Dis. 2025 Oct 15; 232(4):918-922.